159 related articles for article (PubMed ID: 37777058)
1. Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study.
Van Loon E; Tinel C; de Loor H; Bossuyt X; Callemeyn J; Coemans M; De Vusser K; Sauvaget V; Olivre J; Koshy P; Kuypers D; Sprangers B; Van Craenenbroeck AH; Vaulet T; Anglicheau D; Naesens M
Am J Kidney Dis; 2024 Apr; 83(4):467-476. PubMed ID: 37777058
[TBL] [Abstract][Full Text] [Related]
2. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10/creatinine testing in pediatric kidney transplant recipients.
Barrett-Chan E; Wang L; Bone J; Thachil A; Vytlingam K; Blydt-Hansen T
Pediatr Transplant; 2024 May; 28(3):e14718. PubMed ID: 38553815
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection.
Tinel C; Devresse A; Vermorel A; Sauvaget V; Marx D; Avettand-Fenoel V; Amrouche L; Timsit MO; Snanoudj R; Caillard S; Moulin B; Olagne J; Essig M; Gwinner W; Naesens M; Marquet P; Legendre C; Terzi F; Rabant M; Anglicheau D
Am J Transplant; 2020 Dec; 20(12):3462-3476. PubMed ID: 32342614
[TBL] [Abstract][Full Text] [Related]
5. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
[TBL] [Abstract][Full Text] [Related]
6. Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection.
Mincham CM; Gibson IW; Sharma A; Wiebe C; Mandal R; Rush D; Nickerson P; Ho J; Wishart DS; Blydt-Hansen TD
Pediatr Transplant; 2018 Aug; 22(5):e13202. PubMed ID: 29696778
[TBL] [Abstract][Full Text] [Related]
7. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
Hirt-Minkowski P; Rush DN; Gao A; Hopfer H; Wiebe C; Nickerson PW; Schaub S; Ho J
Transplantation; 2016 Sep; 100(9):1988-96. PubMed ID: 27548845
[TBL] [Abstract][Full Text] [Related]
8. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
Blydt-Hansen TD; Gibson IW; Gao A; Dufault B; Ho J
Transplantation; 2015 Apr; 99(4):797-804. PubMed ID: 25222013
[TBL] [Abstract][Full Text] [Related]
9. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients.
Ho J; Sharma A; Kroeker K; Carroll R; De Serres S; Gibson IW; Hirt-Minkowski P; Jevnikar A; Kim SJ; Knoll G; Rush DN; Wiebe C; Nickerson P
BMJ Open; 2019 Apr; 9(4):e024908. PubMed ID: 30975673
[TBL] [Abstract][Full Text] [Related]
10. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection.
Jackson JA; Kim EJ; Begley B; Cheeseman J; Harden T; Perez SD; Thomas S; Warshaw B; Kirk AD
Am J Transplant; 2011 Oct; 11(10):2228-34. PubMed ID: 21812928
[TBL] [Abstract][Full Text] [Related]
11. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.
Hricik DE; Nickerson P; Formica RN; Poggio ED; Rush D; Newell KA; Goebel J; Gibson IW; Fairchild RL; Riggs M; Spain K; Ikle D; Bridges ND; Heeger PS;
Am J Transplant; 2013 Oct; 13(10):2634-44. PubMed ID: 23968332
[TBL] [Abstract][Full Text] [Related]
12. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage.
Arnau A; Benito-Hernández A; Ramos-Barrón MA; García-Unzueta MT; Gómez-Román JJ; Gómez-Ortega JM; López-Hoyos M; San Segundo D; Ruiz JC; Rodrigo E
Ann Transplant; 2021 Mar; 26():e929491. PubMed ID: 33686050
[TBL] [Abstract][Full Text] [Related]
13. Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients.
Rabant M; Amrouche L; Morin L; Bonifay R; Lebreton X; Aouni L; Benon A; Sauvaget V; Le Vaillant L; Aulagnon F; Sberro R; Snanoudj R; Mejean A; Legendre C; Terzi F; Anglicheau D
Am J Transplant; 2016 Jun; 16(6):1868-81. PubMed ID: 26694099
[TBL] [Abstract][Full Text] [Related]
14. Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status.
Lubetzky ML; Salinas T; Schwartz JE; Suthanthiran M
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1565-1577. PubMed ID: 33906907
[TBL] [Abstract][Full Text] [Related]
15. Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.
Mayer KA; Omic H; Weseslindtner L; Doberer K; Reindl-Schwaighofer R; Viard T; Tillgren A; Haindl S; Casas S; Eskandary F; Heinzel A; Kozakowski N; Kikić Ž; Böhmig GA; Eder M
Clin Transplant; 2022 Nov; 36(11):e14785. PubMed ID: 35894263
[TBL] [Abstract][Full Text] [Related]
16. Urinary CXCL10 Measurement in Late Renal Allograft Biopsies Predicts Outcome Even in Histologically Quiescent Patients.
Handschin J; Wehmeier C; Amico P; Hopfer H; Dickenmann M; Schaub S; Hirt-Minkowski P
Transplant Proc; 2021 Sep; 53(7):2168-2179. PubMed ID: 34419254
[TBL] [Abstract][Full Text] [Related]
17. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.
Ho J; Rush DN; Krokhin O; Antonovici M; Gao A; Bestland J; Wiebe C; Hiebert B; Rigatto C; Gibson IW; Wilkins JA; Nickerson PW
Transplantation; 2016 Mar; 100(3):648-54. PubMed ID: 26906940
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation.
Tinel C; Vermorel A; Picciotto D; Morin L; Devresse A; Sauvaget V; Lebreton X; Aouni L; Prié D; Brabant S; Avettand-Fenoel V; Scemla A; Timsit MO; Snanoudj R; Legendre C; Terzi F; Rabant M; Anglicheau D
Front Immunol; 2020; 11():604353. PubMed ID: 33362789
[TBL] [Abstract][Full Text] [Related]
19. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
Karason K; Jernås M; Hägg DA; Svensson PA
BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
